Anastasia V. Koloshkina
ORCID: 0000-0002-5200-7672
· 1 paper in corpus
article
2023
BACKGROUND: An in-depth study of the pathogenesis of adenomyosis and the development of new therapeutic approaches are extremely relevant. Atosiban, a competitive oxytocin receptor antagonist, may be a promising drug with a potential therap…